To coagulate, ligate, or both: a randomized study comparing the safety and efficacy of two endoscopic approaches for managing gastric antral vascular ectasia in cirrhotic patients

Egyptian Liver Journal

Table 4 Comparison between pre- and post-treatment data in the two groups

Comparative factors	Group I: combined therapy group			Group II: EBL group		P Value
Comparative factors	Pre-treatment	Post treatment (after 6 months follow-up)	P value	Pre-treatment	Post treatment (after 6 months follow-up)	P Value
Hemoglobin (g/dl)	6.86 ± 1.25	9.78 ± 1.68	0.001**	7.71 ± 1.66	10.04 ± 1.93	0.001**
Hospitalization	1.60 ± 1.00	0.40 ± 0.88	0.003**	1.50 ± 1.05	0.40 ± 0.82	0.003**
Transfusion	3.90 ± 2.55	0.70 ± 1.98	0.001**	3.20 ± 2.24	0.95 ± 1.88	0.001**

Data are expressed as mean (SD). Statistically significant values are in bold
P > 0.05 = not significant, *P < 0.05 = significant, **P < 0.01 = highly significant